T2 Biosystems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	7.19	22.31	28.06	18.13	8.34	10.5	4.67	4.08	2.81	0.12	Upgrade
Revenue Growth (YoY)	-67.75%	-20.50%	54.76%	117.52%	-20.62%	125.03%	14.36%	45.04%	2263.87%	-55.26%	Upgrade
Cost of Revenue	15.36	21.01	20.7	21.28	16.76	15.4	12.03	6.87	1.74	0	Upgrade
Gross Profit	-8.17	1.3	7.36	-3.15	-8.43	-4.9	-7.36	-2.79	1.07	0.12	Upgrade
Selling, General & Admin	24.83	30.63	28.53	22.09	27.3	25.7	22.76	24.08	19.09	11.02	Upgrade
Research & Development	14.15	25.72	21.8	16.11	16.33	14.49	23.73	24.01	25.36	19.78	Upgrade
Other Operating Expenses	2.51	0.15	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	41.49	56.49	50.33	38.21	43.63	40.19	46.49	48.09	44.46	30.8	Upgrade
Operating Income	-49.66	-55.2	-42.97	-41.36	-52.06	-45.09	-53.85	-50.88	-43.38	-30.68	Upgrade
Interest Expense / Income	5.34	6.08	7.6	5.52	7.35	6.68	8.91	4.1	1.97	0.72	Upgrade
Other Expense / Income	-4.93	0.72	-1.33	-0.08	-0.4	-0.62	-0.33	-0.17	-0.06	-0.01	Upgrade
Pretax Income	-50.08	-62	-49.24	-46.8	-59.01	-51.15	-62.43	-54.8	-45.29	-31.39	Upgrade
Net Income	-50.08	-62	-49.24	-46.8	-59.01	-51.15	-62.43	-54.8	-45.29	-31.39	Upgrade
Preferred Dividends	0	0.33	0	0	0	0	0	0	0	4.57	Upgrade
Net Income Common	-50.08	-62.33	-49.24	-46.8	-59.01	-51.15	-62.43	-54.8	-45.29	-35.96	Upgrade
Shares Outstanding (Basic)	3	0	0	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	3	0	0	0	0	0	0	0	0	0	Upgrade
Shares Change	5017.31%	60.53%	30.93%	166.60%	12.20%	26.24%	23.51%	26.90%	136.31%	521.86%	Upgrade
EPS (Basic)	-19.19	-1222.14	-1550.00	-1950.00	-6500.00	-6300.00	-9700.00	-10550.00	-11050.00	-20750.00	Upgrade
EPS (Diluted)	-19.19	-1222.14	-1550.00	-1950.00	-6500.00	-6300.00	-9700.00	-10550.00	-11050.00	-20750.00	Upgrade
Free Cash Flow	-48.33	-50.97	-39.33	-44.02	-46.12	-40.73	-50.19	-51.93	-45.44	-30.27	Upgrade
Free Cash Flow Per Share	-18.52	-999.31	-1238.00	-1813.83	-5067.49	-5021.23	-7810.71	-9980.30	-11081.74	-17445.67	Upgrade
Gross Margin	-113.58%	5.81%	26.21%	-17.37%	-101.12%	-46.70%	-157.78%	-68.43%	38.14%	100.00%	Upgrade
Operating Margin	-690.45%	-247.46%	-153.16%	-228.11%	-624.57%	-429.43%	-1154.14%	-1247.01%	-1542.23%	-25782.35%	Upgrade
Profit Margin	-696.19%	-279.46%	-175.50%	-258.12%	-707.93%	-487.17%	-1337.93%	-1343.24%	-1610.02%	-30218.49%	Upgrade
Free Cash Flow Margin	-671.88%	-228.50%	-140.19%	-242.77%	-553.35%	-387.91%	-1075.74%	-1272.77%	-1615.32%	-25435.29%	Upgrade
EBITDA	-42.53	-53.65	-39.11	-38.12	-48.02	-42.02	-50.58	-48.43	-41.86	-29.98	Upgrade
EBITDA Margin	-591.26%	-240.52%	-139.38%	-210.28%	-576.06%	-400.21%	-1084.03%	-1186.91%	-1488.02%	-25191.60%	Upgrade
Depreciation & Amortization	2.21	2.27	2.54	3.16	3.64	2.45	2.94	2.28	1.47	0.69	Upgrade
EBIT	-44.73	-55.92	-41.65	-41.28	-51.66	-44.47	-53.52	-50.71	-43.32	-30.67	Upgrade
EBIT Margin	-621.91%	-250.70%	-148.42%	-227.69%	-619.76%	-423.53%	-1147.04%	-1242.79%	-1540.10%	-25772.27%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).